NOMD
$10.00
Nomad Foods Limited, together with its subsidiaries, manufactures, markets, and distributes a range of frozen food products in the United Kingdom and internationally.
Recent News
Nomad Foods (NOMD) Price Target Trimmed by Mizuho Following Latest Earnings Report
Nomad Foods Limited (NYSE:NOMD) is included among the 13 Best Defensive Dividend Stocks for 2025. On March 3, Mizuho lowered its price recommendation on Nomad Foods Limited (NYSE:NOMD) to $13 from $15. It reiterated an Outperform rating on the shares. The firm described the company’s outlook as “disappointing” and said it reduced its estimates following the […]
Is Clorox's International Expansion Key to Its Long-Term Success?
CLX's international push gains traction: segment sales rose 7% to $294M and EBIT jumped 48%, highlighting emerging markets as a key growth driver.
A Look At Nomad Foods (NOMD) Valuation After Prolonged Share Price Weakness
Why Nomad Foods Is On Investors’ Radar Nomad Foods (NOMD) is drawing attention after a stretch of weaker share performance, with the stock down over the past week, month, and past 3 months, prompting fresh questions about its valuation. See our latest analysis for Nomad Foods. That weak recent run extends a tougher stretch for holders, with the 1 year total shareholder return down 47.01% and the 5 year total shareholder return down 56.56%, suggesting momentum has been fading despite Nomad...
Does Nomad Foods (NOMD) Offer Value After A 47% One-Year Share Price Slide?
If you are wondering whether Nomad Foods is a bargain or a value trap at its recent price of US$10.33, you are in the right place to size up what the market may be pricing in. The stock has experienced a 8.3% decline over the last week, a 18.0% fall over the past month, a 15.0% drop year to date, and a 47.0% fall over the last year, which may have changed how investors see its risk and potential. These moves sit against a backdrop of ongoing interest in packaged and frozen food companies,...
Brown-Forman's Q3 Earnings Beat Mark, Organic Sales Rise 1% Y/Y
BF.B beats Q3 estimates with 2% sales growth and higher margins, but weak U.S. demand and macro pressures keep the outlook cautious for fiscal 2026.